People

Powder characterization specialist Freeman Technology has hired Doug Millington-Smith as Applications Specialist at the company's UK headquarters. As Applications Specialist, he will support users of the company's FT4 Powder Rheometer, which is used for characterization of powders for a wide variety of uses, including inhalation. Managing Director Tim Freeman … [Read more...] about Doug Millington-Smith joins Freeman Technology

Bangladeshi pharmaceutical company Beximco Pharma has announced the resignation of Ahsanul Karim from the Board of Directors effective as April 3, 2013 and the appointment of Faheemul Huq as a Non-Executive Director. Beximco manufactures a variety of dosage forms including metered dose inhalers, dry powder inhalers, inhalation solutions for nebulization, and nasal … [Read more...] about Beximco announces board changes

Alexza Pharmaceuticals has hired Peter W. Schineller as its new Senior VP and Chief Commercial Officer, responsible for global commercialization of the company's Adasuve Staccato inhaled loxapine. The FDA approved Adasuve for the treatment of agitation in patients with schizophrenia or bipolar I disorder in December 2012. In Europe, the product was approved in … [Read more...] about Alexza hires Peter Schineller as Senior VP and Chief Commercial Officer

Inhaled pharmaceutical company Prosonix has hired Cécile Miles as its Chief Business Officer. She had been Commercial Director, Europe for the Arrow Group, part of Watson (now Actavis) since May 2011. Prior to Arrow, she had worked in various capacities at Ark Therapeutics, PLIVA, Ranbaxy, and Fisons. Miles said, "I am very excited to be joining the Prosonix team … [Read more...] about Prosonix names Cécile Miles as Chief Business Officer

Pearl Therapeutics, which is developing several inhaled drugs, has announced that it has hired Michael Riebe as VP, Pharmaceutical Development and Research, effective immediately. Riebe, a past chair and current steering committee member of the AAPS Inhalation and Nasal Technology Focus Group, was most recently VP of Research and Development at iCeutica and previously … [Read more...] about Pearl Therapeutics hires Michael Riebe

Discovery Laboratories has named John G. Cooper as President and CEO replacing W. Thomas Amick, who had been chairman of the board since March 2007 and CEO since October 2010. Cooper was Executive VP and CFO from 2002-2010 and has served as President and CFO since in 2010. He will continue as CFO. The company has also appointed John R. Leone chairman of the board … [Read more...] about New CEO, board appointments for Discovery Labs

Trimel Pharmaceuticals has named Tom Rossi as CEO to replace Bruce D. Brydon, who has stepped down as CEO. Rossi has been President of Trimel since he joined the company in August 2011 and also became Chief Operating Officer in March 2012. Brydon, who will continue as chairman of the board of directors, commented, "After 18 months as a reporting issuer on the … [Read more...] about Trimel names Tom Rossi new CEO

Alexza Pharmaceuticals has announced the appointment of J. Kevin Buchi to its board of directors. Buchi, who was Corporate Vice President, Global Branded Products at Teva Pharmaceutical Industries from October 2011 until May 2012, has over 30 years of experience in the pharmaceutical industry. Alexza's Adasuve loxapine inhalation powder for the treatment of … [Read more...] about Alexza appoints J. Kevin Buchi to board of directors